PRL and benign prostatic hyperplasia: Serum concentrations of prolactin (PRL), insulin‐like growth factor‐1 (IGF‐1) and 25 hydroxyvitamin D3 (25‐OHD3) were analysed to investigate their possible involvement in the pathogenesis of benign prostatic hyperplasia (BPH).